China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of ACEI/ARB versus Non-ACEI/ARB Antihypertensive Drugs on the Incidence of Diabetes in Hypertensive Patients at High Risk of Diabetes: An Open-Label, Parallel-Group, Individual-Level, Randomize'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135716
Registration Time: 2026/11/01
Type: Interventional study
Primary Sponsor: The First Affiliated Hospital of USTC
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349133
Published by HT Digital Content Services with permission from Health Daily Digest....